A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts

YANG, H ; EAVES, C ; NG, J ; LI, S ; YAO, X ; EAVES, A. C ; JONES, R ; ANDERSSON, B. S ; SHPALL, E. J ; DE LIMA, M ; LEE, M. S ; CHAMPLIN, R. E ; MCMANNIS, J. D ; ROBINSON, S. N ; NIU, T ; DECKER, W. K ; XING, D

Basingstoke: Nature Publishing Group

Texto completo disponível

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

YILMAZ, M ; CHEMALY, R. F ; CHAMPLIN, R. E ; QAZILBASH, M. H ; HAN, X. Y ; THALL, P. F ; FOX, P. S ; TARRAND, J. J ; DE LIMA, M. J ; HOSING, C. M ; POPAT, U. R ; SHPALL, E

Basingstoke: Nature Publishing Group

Texto completo disponível

Adenoviral Infections in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Single Center Experience

Yilmaz, Musa ; Chemaly, Roy F. ; Han, Xiang Y. ; Thall, Peter F. ; Fox, Patricia S. ; Tarrand, Jeffrey J. ; De Lima, Marcos J. ; Hosing, Chitra M. ; Popat, Uday R. ; Shpall, Elizabeth ; Champlin, Richard E. ; Qazilbash, Muzaffar H.

Texto completo disponível

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Goyal, S D ; Zhang, M-J ; Wang, H-L ; Akpek, G ; Copelan, E A ; Freytes, C ; Gale, R P ; Hamadani, M ; Inamoto, Y ; Kamble, R T ; Lazarus, H M ; Marks, D I ; Nishihori, T ; Olsson, R F ; Reshef, R ; Ritchie, D S ; Saber, W ; Savani, B N ; Seber, A ; Shea, T C ; Tallman, M S ; Wirk, B ; Bunjes, D W ; Devine, S M ; de Lima, M ; Weisdorf, D J ; Uy, G L

England: Nature Publishing Group

Texto completo disponível

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

KEBRIAEI, P ; SALIBA, R. M ; CHAMPLIN, R. E ; KHOURI, I. F ; MA, C ; IPPOLITI, C ; COURIEL, D. R ; DE LIMA, M ; GIRALT, S ; QAZILBASH, M. H ; GAJEWSKI, J. L ; HA, C. S

Basingstoke: Nature Publishing Group

Texto completo disponível

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

QAZILBASH, M. H ; SALIBA, R. M ; KEBRIAEI, P ; POPAT, U ; ALOUS, A. M ; CHAMPLIN, R. E ; GIRALT, S. A ; HOSING, C ; MENDOZA, F ; QURESHI, S. R ; WEBER, D. M ; WANG, M ; FLOSSER, T ; COURIEL, D. R ; DE LIMA, M

Basingstoke: Nature Publishing Group

Texto completo disponível

Comorbidity indices in hematopoietic stem cell transplantation: a new report card

ALAMO, J ; SHAHJAHAN, M ; LAZARUS, H. M ; DE LIMA, M ; GIRALT, S. A

Basingstoke: Nature Publishing Group

Texto completo disponível

Concurrent blinatumomab and donor lymphocyte infusions for treatment of relapsed pre-B-cell ALL after allogeneic hematopoietic cell transplant

Ueda, M ; de Lima, M ; Caimi, P ; Tomlinson, B ; Little, J ; Creger, R ; Lazarus, H ; Cooper, B

England: Nature Publishing Group

Texto completo disponível

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

HOSING, C ; SALIBA, R. M ; SHAHJAHAN, M ; ESTEY, E. H ; COURIEL, D ; GIRALT, S ; ANDERSSON, B ; CHAMPLIN, R. E ; DE LIMA, M

Basingstoke: Nature Publishing Group

Texto completo disponível

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

DE PADUA SILVA, L ; DE LIMA, M ; RAVANDI, F ; KANTARJIAN, H ; FADERL, S ; KEBRIAEI, P ; GIRALT, S ; DAVISSON, J ; GARCIA-MANERO, G ; CHAMPLIN, R ; ISSA, J.-P

Basingstoke: Nature Publishing Group

Texto completo disponível